Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 512 ug ml-1 | Concentration (IC50) to inhibit the growth of Escherichia coli. | ChEMBL. | 3783584 |
IC50 (functional) | > 512 ug ml-1 | Concentration (IC50) to inhibit the growth of Klebsiella aerogenes. | ChEMBL. | 3783584 |
IC50 (functional) | > 512 ug ml-1 | Concentration (IC50) to inhibit the growth of Serratia marcescens. | ChEMBL. | 3783584 |
IC50 (functional) | > 512 ug ml-1 | Concentration (IC50) to inhibit the growth of Staphylococcus aureus. | ChEMBL. | 3783584 |
IC50 (functional) | > 512 ug ml-1 | Concentration (IC50) to inhibit the growth of Streptococcus faecalis. | ChEMBL. | 3783584 |
IC50 (functional) | > 512 ug ml-1 | Concentration (IC50) to inhibit the growth of Bacillus subtilis | ChEMBL. | 3783584 |
IC50 (functional) | > 512 ug ml-1 | Concentration (IC50) to inhibit the growth of Escherichia coli. | ChEMBL. | 3783584 |
MIC (functional) | > 512 ug ml-1 | Minimum inhibitory concentration (MIC) to control the growth of Escherichia coli strain PCM 2057 | ChEMBL. | 3783584 |
MIC (functional) | > 512 ug ml-1 | Minimum inhibitory concentration (MIC) to control the growth of Klebsiella aerogenes strain PCM 2063 | ChEMBL. | 3783584 |
MIC (functional) | > 512 ug ml-1 | Minimum inhibitory concentration (MIC) to control the growth of Serratia marcescens strain PCM 549. | ChEMBL. | 3783584 |
MIC (functional) | > 512 ug ml-1 | Minimum inhibitory concentration (MIC) to control the growth of Staphylococcus aureus strain PCM 2054. | ChEMBL. | 3783584 |
MIC (functional) | > 512 ug ml-1 | Minimum inhibitory concentration (MIC) to control the growth of Streptococcus faecalis strain PCM 896 | ChEMBL. | 3783584 |
MIC (functional) | > 512 ug ml-1 | Minimum inhibitory concentration (MIC) to control the growth of Bacillus subtilis strain PCM 1949. | ChEMBL. | 3783584 |
MIC (functional) | > 512 ug ml-1 | Minimum inhibitory concentration (MIC) to control the growth of Escherichia coli strain PCM 2057 | ChEMBL. | 3783584 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.